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HOST-PATHOGEN COMPETITION
FOR IRON
The survival of higher organisms
requires constant vigilance against
encroachment by potentially pathogenic
microorganisms. Every portal of entry,
and every potential niche, must be
defended simultaneously against a wide
spectrum of invaders. Each of these
invaders – whether symbiotic or poten-
tially pathogenic – has adopted their own
cunning strategy to avoid detection and
elimination, and to hijack the host’s
nutritional resources and metabolic appa-
ratus to multiply and spread. In response
to these threats humans have evolved a
bewildering array of innate and adaptive
defenses of which our knowledge is still
only in its infancy. Among the innate
defenses are mechanisms designed to
withhold nutritional resources from the
invaders and, of all the nutrients, iron is
by far the most critical. It lies at the
epicenter of most host-pathogen battles
for resource control; it is the equivalent of
crude oil in global geopolitics.
But 32% of the earth’s crust is
composed of iron (and 88% of its core)
making it the most abundant element on
the planet, so why should it be the subject
of such blatant avarice? And what is the
evidence that it is the focus of a fierce
arms race between host and pathogen?
The avarice is generally explained by
the very low solubility of iron compounds
in their usual oxidized ferric state and by
the usefulness of iron’s redox potentials,
which make it a suitable co-factor for
numerous enzymes and pathways.
The evidence for its centrality in host-
pathogen competition comes, inter alia,
from the following sources: (i) most
bacteria have made a disproportionate
genetic investment in processes for iron
acquisition; (ii) many of these genes are
concentrated in islands of high patho-
genicity, are important in defining niche
specificity, and knock-downs are out-
competed by wild types; (iii) there are
over 500 known bacterial siderophores
some with iron binding capacities that
elude the best synthetic chemists (e.g.
1052 M for enterobactin); (iv) genetic
detective work shows that horizontal
capture of iron-acquiring genes has been
essential to niche transitions as enteric
organisms find ways to colonize the low-
iron systemic environment; (v) in
response to these threats, and also to
avoid potential iron-mediated oxidative
damage, the human host has developed a
suite of chaperone and storage proteins
(transferrin, lactoferrin, ferritin, hemo-
pexin, haptoglobin, etc.) and complex
mechanisms for regulating dietary iron
absorption and distribution; and (vi) the
negative acute phase response, in which
plasma iron levels can be decreased by
fourfold or more within hours of an
infection has long been hypothesized to
be an element of the innate immune
system.
The circulating hormone hepcidin,
discovered in 2000, turns out to be the
master regulator of these iron-mediated
mammalian defenses (Ganz, 2011). Hep-
cidin is a 25 amino acid peptide hormone
produced primarily in the liver and
functions by binding to the cellular iron
exporter, ferroportin, causing its loss of
function by internalization. Down reg-
ulation of ferroportin on the basolateral
membrane of enterocytes causes an
intracellular build up of iron which
blocks further absorption at the apical
surface, thus blocking the entry of dietary
iron. Ferroportin inhibition in macro-
phages, the primary medium for iron re-
cycling, blocks this process and results in
its (relatively) safe sequestration for long
periods if necessary. Through this pro-
cess hepcidin orchestrates a major redis-
tribution of body iron at times of infection
and inflammation.
IRON AND MALARIA: NEW
EVIDENCE THAT IRON IS
CRITICAL
A recent paper in Nature Medicine
has brought these themes together and
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provides strong evidence that hepcidin-
mediated iron redistribution represents
an important component of innate
immune defence, at least against malaria
(Portugal et al, 2011). Portugal and
colleagues showed that mice carrying a
Plasmodium berghei blood stage infec-
tion above a certain threshold were
profoundly resistant to a new liver stage
infection when inoculated with sporo-
zoites, the mosquito invasive form of the
parasite (Fig 1). This effect was repro-
ducible across different rodent Plasmo-
dium species and strains. Examination of
liver sections 40–48 h after inoculation
showed a reduction in both number and
size of exoerythrocytic forms (EEFs) in
infected mice compared to controls.
These reductions matched qRT-PCR mea-
sures of infection in the same livers. No
EEFs were observed 72 h after infection in
the mice carrying a blood-stage infection.
Up-regulation of immune related genes
in both the blood stage infected mice
and after secondary sporozoite challenge
suggested that immune mechanisms
could have been responsible for the
impaired liver stage development. The
challenge experiments were repeated in
splenectomized animals, and mice geneti-
cally deficient for T and B cells, natural
killer cells, gd T cells, IFN-g, nitric oxide
synthase, interleukin-10, and myeloid
differentiation factor-88 signalling, C5a-
complement factor or mast cells, in mice
depleted of tumor necrosis factor-a or
IL-6, and in mice treated with the general
anti-inflammatory compound N-acetyl-
cysteine. None of these conditions pre-
vented the protection against a liver-stage
infection in mice that had ongoing blood
stage infection; liver-stage re-infections
were not even partially allowed. The same
was true of immunosuppressed mice
(severe combined immunodeficiency)
upon re-infection. This series of experi-
ments strongly suggested that classic
components of adaptive or innate immu-
nity where not involved. Hepatocyte
apoptosis was also excluded.
The reduction in number and size of
EEFs suggested that a nutrient or growth
factor might be limiting development.
Hamp mRNA, encoding hepcidin, was
found up-regulated (average fivefold) in
mice with a blood-stage infection, con-
firming previous observations (Armitage
et al, 2009). Hepcidin mRNA levels
correlated with blood-stage infection
level and, above a threshold, were
inversely correlated to P. berghei liver
infection. These increased hepcidin
levels caused a redistribution of iron
with increased levels in macrophages and
the spleen, but reduced levels in hepato-
cytes. Previous studies on Plasmodium-
infected hepatoma cells had revealed a
reduction in ferroportin (regulating iron
efflux) and an increase in divalent metal
transporter-1 (regulating influx) suggest-
ing that the parasite was re-engineering
the intra-cellular milieu to benefit its own
growth (Albuquerque et al, 2009), and
strongly implying that iron acquisition
might be essential for the parasite
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Figure 1. Inter-kingdom signalling by Plasmodium parasites diverts host iron (Fe) supply for both offence and defence. FPN, ferroportin, DMT1, divalent
metal transporter, HAMP, hepcidin gene, PBMC, peripheral blood mononuclear cells, EEF, exoerythrocytic forms of parasite.
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complete development. This was further
confirmed by demonstrating that addi-
tion of iron chelators markedly inhibited
EEF development in a dose-dependent
manner, whereas supplementation with
iron markedly stimulated development.
Final confirmation that the inhibition
of super-infection was mediated by the
hepcidin-iron axis was obtained in mice
with no ongoing blood-stage infection
but over-expressing hepcidin or follow-
ing hepcidin peptide administration.
Together these results provide the best
demonstration to date of what has been
suspected for some decades, namely that
host-pathogen competition for iron can
be a critical determinant of infectivity.
The ability of the blood-stage parasite to
protect its niche by out-competing
another plasmodial population through
host metabolism manipulation repre-
sents a beautiful illustration of inter-
kingdom signalling and of the importance
of nutrient supply to microorganism
virulence. The fact that iron is the critical
nutrient should come as no surprise.
SIGNIFICANCE FOR GLOBAL
HEALTH
It is rare for a basic-science study on
molecular mechanisms of disease in a
mouse model to catch the attention of the
global public health community – but this
one should. In 2005 a very large iron
and zinc intervention trial in Pemba,
Tanzania was prematurely terminated by
its data safety monitoring board because
the children receiving iron had signifi-
cantly more serious adverse events
(deaths and hospitalizations) than those
receiving zinc or placebo (Sazawal et al,
2006). The result has been ascribed to a
malign interaction between iron and
malaria, and caused WHO to recommend
suspension of iron supplementation pro-
grammes in malarious regions. This has
created a policy vacuum leaving tens of
millions of children vulnerable to the
short- and longer-term consequences of
iron deficiency.
» . . .nutritional immunity
with potentially major
consequences for global
health. «
By demonstrating how crucial the iron-
hepcidin axis is in malaria, the proof-of-
principle experiments by Portugal et al
(Portugal et al, 2011) will add new
impetus to discovery science in nutri-
tional immunity with potentially major
consequences for global health. Does the
redistribution of iron to macrophages
elevate the risk of bacteraemia in
malaria? Does iron accelerate disease
progression in HIV? Does elevated
iron status increase susceptibility to
TB? Do other hepcidin-inducing infec-
tions exacerbate these effects? There is
epidemiological evidence pointing to
each of these possibilities, but solid proof
at the molecular level would greatly
enhance the development of preventative
and therapeutic interventions. There may
then be a significant role for hepcidin
agonists, antagonists or mimetics.
The author declares he has no conflict of
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